Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01199666 · ClinicalTrials.gov registry record · NA
Text Message Reminder-Recalls For Early Childhood Vaccination
A NA study of Vaccination, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 2,586
- Enrollment target
- 1
- Study location
NCT01199666 is a NA study of Vaccination that has completed, run by Columbia University. The registered enrollment target is 2,586 participants, below the 10,018-participant average among 12 other Vaccination trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01199666, a NA study of Vaccination, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,586 participants
- Enrollment target
- 1
- Study location
Study Summary
Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable disease persist. Immunization reminder-recalls have been shown to be successful, but have been limited by the ability to identify and reach large target populations in a real-time, automated fashion. Reminder-recalls via text message may offer an innovative opportunity to improve vaccination coverage. Currently, 91% of Americans own a cell phone. Prior research by our team suggests that text messages reminder recalls may be an effective tool to remind parents about their children's vaccines. In this study, the investigators will demonstrate the effectiveness of tailored text message appointment and immunization reminders linked to a well-established and functional immunization registry to increase coverage rates and timeliness of the sentinel vaccines of MMR and HepA. The investigators will target parents of young children from an underserved population that is primarily Latino, with low socioeconomic status.
Conditions Studied
Interventions
- OTHER Text message
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,586 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01199666
The ClinicalTrials.gov registry entry for NCT01199666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,586 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,018-participant average among 12 other Vaccination trials with a reported enrollment target (74% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Text message is the first listed.
NCT01199666 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01199666 about?
NCT01199666 is a clinical study titled "Text Message Reminder-Recalls For Early Childhood Vaccination". Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable diseas...
What is the current status of trial NCT01199666?
This trial is currently completed. It is a NA study. The enrollment target is 2,586 participants. The study started on 2011-06. Estimated completion is 2013-07.
What conditions does trial NCT01199666 study?
This clinical trial studies the following conditions: Vaccination.
What interventions are being tested in trial NCT01199666?
The interventions under investigation include: Text message (OTHER).
Who is sponsoring clinical trial NCT01199666?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01199666 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
ARISe at UMass Chan
RECRUITING · NA
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
COMPLETED · NA
-
P3+ Intervention Phase
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.